dc.contributorUniversidade de São Paulo (USP)
dc.contributorUniversidade Estadual Paulista (Unesp)
dc.contributorInstitute for Technological Research (IPT)
dc.contributorUniversity of Alberta
dc.date.accessioned2020-12-12T00:57:33Z
dc.date.accessioned2022-12-19T20:36:25Z
dc.date.available2020-12-12T00:57:33Z
dc.date.available2022-12-19T20:36:25Z
dc.date.created2020-12-12T00:57:33Z
dc.date.issued2020-03-15
dc.identifierJournal of Drug Targeting, v. 28, n. 3, p. 259-270, 2020.
dc.identifier1029-2330
dc.identifier1061-186X
dc.identifierhttp://hdl.handle.net/11449/198046
dc.identifier10.1080/1061186X.2019.1663858
dc.identifier2-s2.0-85073945946
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/5378680
dc.description.abstractNanocrystals and lipid-based nanosystems have the potential to play a crucial role in a significant shift in the treatment of ophthalmic diseases. These drug delivery systems allow overcoming the barriers imposed by anatomy and physiology of the organ of vision. This review aims to present new perspectives for these innovative preparations, emphasising the applications of the nanocrystal and lipid-based nanosystem while outlining their advantages and the drawbacks. The in vivo performance of the lipid-based nanosystems was highlighted. Lipid-based nanosystems and nanocrystals showed a prolonged effect, improved ocular bioavailability, upper therapeutic efficacy, higher permeation, prolonged residence time, and sustained drug release, compared to the current applications. Well-established and innovative developments updates of these systems are highlighted herein.
dc.languageeng
dc.relationJournal of Drug Targeting
dc.sourceScopus
dc.subjectdrug delivery
dc.subjectlipid-based nanosystems
dc.subjectNanocrystals
dc.subjectocular bioavailability
dc.subjectophthalmic
dc.titleAdvances in ophthalmic preparation: the role of drug nanocrystals and lipid-based nanosystems
dc.typeOtros


Este ítem pertenece a la siguiente institución